期刊
PLANT MOLECULAR BIOLOGY
卷 57, 期 1, 页码 101-113出版社
SPRINGER
DOI: 10.1007/s11103-004-6832-x
关键词
Gaucher disease; human acid beta-glucosidase; pharmaceutical proteins; seed-specific expression; transgenic plants
Gaucher disease, the most common genetic lysosomal disorder, is caused by the lack of functional acid beta-glucosidase (GCase) and is currently treated at a very high cost by enzyme replacement therapy. In an attempt to provide a safe and cost-effective production system, human placental GCase was produced and purified from transgenic tobacco seeds. Plant-derived recombinant GCase was found to be enzymatically active, uptaken by human fibroblasts and free of immunogenic xylose and fucose residues. This report demonstrates the potential of plant bioreactors in the large-scale production of injectable proteins required for lifelong therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据